Timolol Maleate
NDC 16571-225, Timolol Maleate, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-225
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207556
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-225 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIMOLOL MALEATE20 mg/1
Pharmacologic classes
Adrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-225-01 | 16571022501 | 100 TABLET in 1 BOTTLE (16571-225-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0bc40b2c-65eb-4095-87e6-4752d5b19a3a
Use it
Look up 16571-225 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-225 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-225. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.